Junqi Niu

13PUBLICATIONS
50CO-AUTHORS
Nanotoxicology, health and safetyMedical molecular engineering of nucleic acids and proteinsGastroenterology and hepatologyCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 12, 2026
Stimulation of the STING pathway leads to inhibition of HBV replication: insights into the role of hepatic macrophages.

|Sep 05, 2025
Response to letter to the editor "Methodological considerations for recombinant human serum albumin clinical translation".

Xinrui Wang, Junqi Niu

|Jul 23, 2025
A randomized, phase Ib trial of recombinant human serum albumin in cirrhotic patients with ascites.

Xinrui Wang, Wanyu Li, Fei Kong

|May 16, 2025
Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study.

Ningning Zhang, Tian Liu, Ming Luo

|Dec 14, 2024
Safety, Pharmacokinetics and Antiviral Efficacy of Capsid Assembly Modulator Freethiadine in Healthy Volunteers and Chronic Hepatitis B Patients.

Xiaojiao Li, Jia Xu, Jixuan Sun

|Aug 10, 2024
System analysis based on weighted gene co-expression analysis identifies SOX7 as a novel regulator of hepatic stellate cell activation and liver fibrosis.

Yuwei Liu, Xiaomei Wang, Zhongfeng Wang

Pageof 3

Frequent Collaborators

2 joint publications

Mingyuan Zhang

2 joint publications

Ruihong Wu

2 joint publications

Yanhua Ding

2 joint publications

Jinlin Hou